Skip to main navigation
Skip to search
Skip to main content
Augusta University Research Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Grants
Scholarly Output
Datasets
Activities
Prizes
Search by expertise, name or affiliation
Development of endothelin receptor antagonists as potential therapeutic agents
Adviye Ergul
Physiology
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Development of endothelin receptor antagonists as potential therapeutic agents'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Bosentan
83%
Endothelin Receptor Antagonists
78%
Endothelin-1
63%
Pulmonary Hypertension
58%
Heart Failure
42%
Endothelin Receptors
40%
Familial Primary Pulmonary Hypertension
38%
Patents
35%
Vasoconstrictor Agents
32%
Essential Hypertension
30%
Mitogens
29%
Treatment Failure
28%
Atherosclerosis
23%
Clinical Trials
19%
Hypertension
19%
Therapeutics
9%
Chemical Compounds
Endothelin Receptor Antagonist
100%
Endothelin-1
87%
Antagonist
54%
Bosentan
52%
Mitogen
41%
Agent Interacting With Transmitter, Hormone or Drug Receptor
32%
Application
9%